NCT04893876View on ClinicalTrials.gov

The OPERa Study: Evaluating QoL After Rectal Cancer Surgery

Not yet recruitingOBSERVATIONAL
Enrollment

1,200

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

September 30, 2028

Study Completion Date

September 30, 2029

Conditions
Rectal CancerQuality of LifeBowel DysfunctionSexual DysfunctionUrinary DysfunctionEmotional DistressSurgery
All Listed Sponsors
lead

Jewish General Hospital

OTHER

NCT04893876 - The OPERa Study: Evaluating QoL After Rectal Cancer Surgery | Biotech Hunter | Biotech Hunter